Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?

Documenti analoghi

• Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma
  di: Lee, Su-Min, et al.
  Pubblicazione: (2015)
• Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients
  di: Jonska-Gmyrek, Joanna, et al.
  Pubblicazione: (2018)
• Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19
  di: Zhu, Shiping, et al.
  Pubblicazione: (2020)
• The Role of Pretreatment Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in the Diagnosis of Breast Cancer: Predicting Lymph Node Metastasis
  di: Eroglu, Aydan, et al.
  Pubblicazione: (2013)
• Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
  di: Wang, Huan, et al.
  Pubblicazione: (2020)